Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wangchun Lin"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Purpose: Results from the LAUNCH trial suggest transarterial chemoembolization (TACE) in combination with lenvatinib is significantly more effective than lenvatinib as a first-line treatment option for advanced hepatocellular carcinoma (HCC). However
Externí odkaz:
https://doaj.org/article/cb692374d39c4b79b62b3d82b9808c40
Autor:
Tingting Lu, Yufan Huang, Zhongjie Cai, Wangchun Lin, Xiaoxiao Chen, Ruijia Chen, Yingying Hu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: The EMPOWER-LUNG 3 clinical trial has shown that cemiplimab plus chemotherapy (CCT) significantly extended overall survival (OS) and progression-free survival (PFS) for patients with advanced non-small cell cancer (NSCLC) compared to plac
Externí odkaz:
https://doaj.org/article/21dc4a458c194ffd9d465093eebc55a5
Publikováno v:
Annals of clinical and laboratory science. 52(6)
Shc SH2 domain-binding protein (SHCBP1) is involved in regulating tumour progression in a variety of tumour types. The aim of this study was to analyze the prognostic landscape of SHCBP1 in pan-cancer and investigate the relationship between SHCBP1 e
Publikováno v:
Zhejiang Daxue xuebao. Lixue ban, Vol 34, Iss 2, Pp 223-227 (2007)
通过生物化学成分测定,分析黑斑口虾蛄(Oratosquilla kempi)胚胎和幼体不同发育时期的水分、总脂和脂肪酸的组成及体积分数、质量分数变化.结果显示,黑斑口虾蛄在胚胎和幼体的发育过程
Externí odkaz:
https://doaj.org/article/25f16566315a4e19a289e477a58299a3
Publikováno v:
Cancer Weekly; 9/26/2023, p692-692, 1p
Publikováno v:
Immunotherapy Weekly; 8/8/2023, p675-675, 1p